NASDAQ:SNBR • US83125X1037
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SLEEP NUMBER CORP (SNBR).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-01-16 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-11-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-11 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-03-06 | Wedbush | Maintains | Neutral -> Neutral |
| 2025-03-06 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-10-31 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-09-17 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-08-01 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-04-25 | UBS | Maintains | Neutral -> Neutral |
| 2024-04-25 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-04-25 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-04-17 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-02-23 | Wedbush | Maintains | Neutral -> Neutral |
| 2023-11-08 | Wedbush | Maintains | Neutral -> Neutral |
| 2023-10-19 | Wedbush | Maintains | Neutral -> Neutral |
| 2023-10-06 | UBS | Maintains | Neutral -> Neutral |
| 2023-07-28 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2023-04-27 | Piper Sandler | Maintains | Neutral |
| 2023-04-20 | Wedbush | Maintains | Neutral |
| 2023-02-23 | UBS | Maintains | Neutral |
| 2023-02-23 | Wedbush | Maintains | Neutral |
| 2023-02-02 | Piper Sandler | Maintains | Neutral |
| 2022-07-28 | UBS | Maintains | Neutral |
| 2022-06-14 | Piper Sandler | Maintains | Neutral |
| 2022-04-21 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.114B -3.23% | 1.887B -10.73% | 1.682B -10.87% | 1.421B -15.53% | 1.394B -1.90% | 1.482B 6.31% | 1.507B 1.69% | |
| EBITDA YoY % growth | 135.3M -46.71% | 112.713M -16.69% | 107.289M -4.81% | 69.635M -35.10% | 87.315M 25.39% | 110.74M 26.83% | 102.41M -7.52% | |
| EBIT YoY % growth | 67.9M -64.91% | 38.67M -43.05% | 40.938M 5.87% | 12.169M -70.27% | 30.559M 151.12% | 57.477M 88.09% | 56.814M -1.15% | |
| Operating Margin | 3.21% | 2.05% | 2.43% | 0.86% | 2.19% | 3.88% | 3.77% | |
| EPS YoY % growth | 1.61 -73.52% | -0.68 -142.24% | -0.90 -32.35% | -3.84 -326.51% | -0.49 87.25% | 0.44 189.58% | 1.18 169.77% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.51 -142.86% | -0.14 62.42% | -0.06 94.39% | -0.19 88.80% | -0.08 84.00% |
| Revenue Q2Q % growth | 335.24M -11.03% | 363.72M -7.51% | 329M 0.33% | 362.12M 5.61% | 339.09M 1.15% |
| EBITDA Q2Q % growth | 11.409M -84.33% | 22.868M 23.48% | 23.582M -36.96% | 18.924M -56.69% | 23.807M 108.67% |
| EBIT Q2Q % growth | -1.727M -126.73% | 7.011M 90.31% | 10.288M 23.80% | 6.28M 488.57% | 9.588M 655.12% |
All data in USD
9 analysts have analysed SNBR and the average price target is 11.22 USD. This implies a price increase of 93.78% is expected in the next year compared to the current price of 5.79.
SLEEP NUMBER CORP (SNBR) will report earnings on 2026-03-12, before the market open.
The consensus EPS estimate for the next earnings of SLEEP NUMBER CORP (SNBR) is -0.51 USD and the consensus revenue estimate is 335.24M USD.
The number of analysts covering SLEEP NUMBER CORP (SNBR) is 9.